Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
For consumers, blockchain offers greater control over data and transactions. This intro explains benefits with relatable scenarios.
21,901 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Hydrogen policy momentum and rising costs are shaping a wide range of outcomes for plug power (plug) stock, with anal...
A high-stakes Senate hearing over Iran policy put the spotlight on intelligence briefings and political risk. The key...
Powell pledges to stay on the Federal Reserve board until the DOJ probe concludes, as Trump presses to replace him. T...
Three growth-focused ETFs have fallen this month as rates move and leadership shifts unsettle risk assets. One fund s...
Hess Midstream signals a major shift from expansion to cash returns, projecting $850-$900 million in adjusted free ca...
Iranian tensions send energy prices higher as LNG and crude flows shift. A handful of U.S. energy stocks have surged ...
Evolution Petroleum Corp reaches a historic 50th consecutive quarterly dividend, delivering a 10.6% yield at a $4.50 ...
In March 2026, Anduril landed a long-term Army contract valued up to $20 billion, moving defense tech from pilots to ...
XRP surged to $1.60 on the regulatory milestone, then faded as macro headwinds and rising yields pressured all risk a...
Zscaler executives argue that AI cannot substitute for 100% reliable inline traffic inspection, even as AI workloads ...
Nasdaq-100 levered ETFs are back in focus as markets swing. While 3x exposure offers amplified moves, daily resets ma...